M. Gorre

6.4k total citations
28 papers, 1.3k citations indexed

About

M. Gorre is a scholar working on Genetics, Hematology and Rheumatology. According to data from OpenAlex, M. Gorre has authored 28 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Genetics, 15 papers in Hematology and 10 papers in Rheumatology. Recurrent topics in M. Gorre's work include Chronic Lymphocytic Leukemia Research (14 papers), Chronic Myeloid Leukemia Treatments (13 papers) and Eosinophilic Disorders and Syndromes (10 papers). M. Gorre is often cited by papers focused on Chronic Lymphocytic Leukemia Research (14 papers), Chronic Myeloid Leukemia Treatments (13 papers) and Eosinophilic Disorders and Syndromes (10 papers). M. Gorre collaborates with scholars based in United States, Germany and Netherlands. M. Gorre's co-authors include Charles L. Sawyers, Neal Rosen, Katharine Ellwood‐Yen, Gabriela Chiosis, Bradley Brasher, Neil P. Shah, S. A. Roumiantsev, John Nicoll, Richard A. Van Etten and Shelly Gunn and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

M. Gorre

27 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Gorre United States 15 551 504 443 286 285 28 1.3k
Mohammad Azam United States 18 856 1.6× 664 1.3× 694 1.6× 318 1.1× 363 1.3× 36 1.6k
Ines Kaupe Austria 10 583 1.1× 411 0.8× 594 1.3× 218 0.8× 236 0.8× 13 1.2k
Catherine Roche‐Lestienne France 22 1.2k 2.1× 1.0k 2.1× 534 1.2× 316 1.1× 478 1.7× 69 2.0k
J V Melo United Kingdom 16 553 1.0× 644 1.3× 280 0.6× 188 0.7× 184 0.6× 26 1.1k
Erica N Evans United States 19 232 0.4× 288 0.6× 487 1.1× 187 0.7× 112 0.4× 44 1.2k
T J Ernst United States 15 491 0.9× 200 0.4× 662 1.5× 423 1.5× 74 0.3× 16 1.7k
Christine M. McMahon United States 18 598 1.1× 251 0.5× 1.1k 2.4× 316 1.1× 63 0.2× 59 1.8k
David Deperthes Canada 17 199 0.4× 402 0.8× 517 1.2× 210 0.7× 53 0.2× 25 1.1k
Wolfgang Warsch Austria 14 637 1.2× 427 0.8× 381 0.9× 415 1.5× 159 0.6× 16 1.2k
Bradley W. Blaser United States 20 613 1.1× 299 0.6× 816 1.8× 630 2.2× 108 0.4× 46 2.1k

Countries citing papers authored by M. Gorre

Since Specialization
Citations

This map shows the geographic impact of M. Gorre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Gorre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Gorre more than expected).

Fields of papers citing papers by M. Gorre

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Gorre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Gorre. The network helps show where M. Gorre may publish in the future.

Co-authorship network of co-authors of M. Gorre

This figure shows the co-authorship network connecting the top 25 collaborators of M. Gorre. A scholar is included among the top collaborators of M. Gorre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Gorre. M. Gorre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dawson, Angelika J., Ingo Schroedter, Matthew D. Seftel, et al.. (2011). Inversion and deletion of 16q22 defined by array CGH, FISH, and RT-PCR in a patient with AML. Cancer Genetics. 204(6). 344–347. 10 indexed citations
2.
Leder, Kevin, Jasmine Foo, Brian J. Skaggs, et al.. (2011). Fitness Conferred by BCR-ABL Kinase Domain Mutations Determines the Risk of Pre-Existing Resistance in Chronic Myeloid Leukemia. PLoS ONE. 6(11). e27682–e27682. 42 indexed citations
3.
4.
Koh, Stephen S., Michael L. Opel, M. Gorre, et al.. (2009). Molecular classification of melanomas and nevi using gene expression microarray signatures and formalin-fixed and paraffin-embedded tissue. Modern Pathology. 22(4). 538–546. 35 indexed citations
5.
Yeh, I‐Tien, et al.. (2009). Clinical validation of an array CGH test for HER2 status in breast cancer reveals that polysomy 17 is a rare event. Modern Pathology. 22(9). 1169–1175. 105 indexed citations
6.
7.
Jilani, Iman, Hagop M. Kantarjian, M. Gorre, et al.. (2008). An immunological method for the detection of BCR-ABL fusion protein and monitoring its activation. Leukemia Research. 32(6). 936–943. 12 indexed citations
8.
Gunn, Shelly, Lynn L. Barron, M. Gorre, et al.. (2008). Array CGH analysis of chronic lymphocytic leukemia reveals frequent cryptic monoallelic and biallelic deletions of chromosome 22q11 that include the PRAME gene. Leukemia Research. 33(9). 1276–1281. 42 indexed citations
9.
Gunn, Shelly, M.H. Afif, M. Gorre, et al.. (2008). Whole-Genome Scanning by Array Comparative Genomic Hybridization as a Clinical Tool for Risk Assessment in Chronic Lymphocytic Leukemia. Journal of Molecular Diagnostics. 10(5). 442–451. 56 indexed citations
10.
Gunn, Shelly, Lynn L. Barron, M. Gorre, et al.. (2008). Array CGH Analysis of Chronic Lymphocytic Leukemia Reveals Frequent Cryptic Monoallelic and Biallelic Deletions of Chromosome 22q11.. Blood. 112(11). 1050–1050. 2 indexed citations
11.
Jilani, Iman, M. Gorre, Hagop M. Kantarjian, et al.. (2007). A potential role for HSP90 inhibitors in the treatment of JAK2 mutant-positive diseases as demonstrated using quantitative flow cytometry. Leukemia & lymphoma. 48(11). 2189–2195. 20 indexed citations
12.
Jilani, Iman, Hagop M. Kantarjian, M. Gorre, et al.. (2007). Phosphorylation levels of BCR-ABL, CrkL, AKT and STAT5 in imatinib-resistant chronic myeloid leukemia cells implicate alternative pathway usage as a survival strategy. Leukemia Research. 32(4). 643–649. 16 indexed citations
13.
Kantarjian, H, Iman Jilani, M. Gorre, et al.. (2006). Heterogeneity in detecting Abl kinase mutations and better sensitivity using circulating plasma RNA. Leukemia. 20(11). 1989–1991. 11 indexed citations
14.
Lancet, Jeffrey E., Ivana Gojo, Maria R. Baer, et al.. (2006). Phase 1, pharmacokinetic (PK) and pharmacodynamic (PD) study of of the Hsp-90 inhibitor, KOS-1022 (17-DMAG), in patients with refractory hematological malignancies. Journal of Clinical Oncology. 24(18_suppl). 2081–2081. 5 indexed citations
15.
16.
Jilani, Iman, Hagop M. Kantarjian, M. Gorre, et al.. (2005). Measurement of Free Circulating Bcr-Abl Fusion Protein and Its Phosphorylation in Patients with Chronic Myeloid Leukemia.. Blood. 106(11). 2006–2006. 2 indexed citations
17.
Chandra, Joya, M. Gorre, Moshe Talpaz, et al.. (2004). Effects of Adaphostin, a Novel Tyrphostin Inhibitor, in Diverse Models of Imatinib Mesylate Resistance.. Blood. 104(11). 2097–2097. 2 indexed citations
18.
Gorre, M. & Charles L. Sawyers. (2002). Molecular mechanisms of resistance to STI571 in chronic myeloid leukemia. Current Opinion in Hematology. 9(4). 303–307. 82 indexed citations
19.
Fahey, John L., John Boscardin, J. K. Thomas, et al.. (2000). Distinct categories of immunologic changes in frail elderly. Mechanisms of Ageing and Development. 115(1-2). 1–20. 74 indexed citations
20.
Mikyas, Yeshi, Najib Aziz, Nina T. Harawa, et al.. (1997). Immunologic activation during pregnancy: serial measurement of lymphocyte phenotype and serum activation molecules in HIV-infected and uninfected women. Journal of Reproductive Immunology. 33(2). 157–170. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mohammad Azam Breakdown of academic impact, for papers by Ines Kaupe Breakdown of academic impact, for papers by Catherine Roche‐Lestienne Breakdown of academic impact, for papers by J V Melo Breakdown of academic impact, for papers by Erica N Evans Breakdown of academic impact, for papers by T J Ernst Breakdown of academic impact, for papers by Christine M. McMahon Breakdown of academic impact, for papers by David Deperthes Breakdown of academic impact, for papers by Wolfgang Warsch Breakdown of academic impact, for papers by Bradley W. Blaser
Rankless by CCL
2026